Company intelligence / Profile preview

AIX Ventures

Palo Alto / Newark / San Francisco Bay Area, California, United Statesaixventures.com ↗

Ownership: Private
Development stage: Other

Overview

AIX Ventures is an early-stage venture capital fund founded in 2021 and based in California. The fund specializes in investments where artificial intelligence is core to the business model and has a strong focus on sectors including healthcare and life sciences. It backs startups developing transformative technologies—such as organoid-based drug discovery platforms and AI-driven protein engineering—often at seed or Series A stages. Recent notable investments include leading Parallel Bio’s $21M Series A round for its human immune organoid drug discovery platform.

Industry: Investors

Beyond the preview

Go deeper on AIX Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AIX Ventures.

Explore the full profile